Related Experiment Video
Updated: Aug 17, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis
Jasper J Haringman1, Roos L Oostendorp, Paul P Tak
1Division of Clinical Immunology and Rheumatology F4-218, Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, NL-1105 AZ, Amsterdam, The Netherlands.
Abstract:
The development of specific targeted therapies, such as anti-TNF-alpha treatment, for chronic inflammatory disorders such as rheumatoid arthritis, has significantly improved treatment, although not all patients respond. Targeting cellular adhesion molecules and chemokines/chemokine receptors as regulators of the extravasation and migration of leukocytes may provide a novel approach for the treatment of these diseases. Moreover, the possibility of developing small-molecule antagonists offers an excellent method for the oral delivery of compounds with a short half-life.
Insights
Targeting cellular adhesion molecules and chemokines offers a novel treatment approach for inflammatory diseases like rheumatoid arthritis when anti-TNF-alpha therapies fail. Small-molecule antagonists may enable convenient oral drug delivery.
Area of Science:
- Immunology
- Pharmacology
- Rheumatology
Background:
- Targeted therapies like anti-TNF-alpha have improved chronic inflammatory disorder treatment.
- Not all patients respond to current targeted therapies, necessitating novel approaches.
Purpose of the Study:
- To explore targeting cellular adhesion molecules and chemokines/chemokine receptors as a novel therapeutic strategy.
- To investigate the potential for small-molecule antagonists for oral delivery in treating inflammatory diseases.
Main Methods:
- Focus on leukocyte extravasation and migration pathways.
- Development of small-molecule antagonists.
Main Results:
- Targeting cellular adhesion molecules and chemokines presents a promising therapeutic avenue.
- Small-molecule antagonists offer potential for oral administration and short half-life compounds.
Conclusions:
- Novel therapeutic strategies targeting leukocyte migration are needed for inflammatory diseases.
- Small-molecule antagonists represent a viable approach for oral drug delivery in this context.
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Acute Inflammation II: Cellular Phase
Intracellular Signaling Affects Focal Adhesions
Some...
